CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells

T. Vaisitti, S. Aydin, D. Rossi, F. Cottino, L. Bergui, G. D'Arena, L. Bonello, A. L. Horenstein, P. Brennan, C. Pepper, G. Gaidano, F. Malavasi, S. Deaglio

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Homing of chronic lymphocytic leukemia (CLL) cells to sites favoring growth, a critical step in disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 CLL patients was divided into migrating and nonmigrating subsets according to chemotaxis toward CXCL12. Migrating patients phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) proteins more than nonmigrating patients (P <0.0002). CD38 expression was the parameter most strongly associated with heightened CXCL12 signaling (P <0.0001), confirmed by independent statistical approaches. Consistent with this observation, CD38 CLL cells in samples with bimodal CD38 expression responded less to CXCL12 than the intact clone (P <0.003). Furthermore, lentivirus-induced de novo expression of CD38 was paralleled by increased responses to CXCL12, as compared with cells infected with a control virus. CD38 ligation with agonistic monoclonal antibodies (mAbs) enhanced CXCL12 signaling, whereas blocking anti-CD38 mAbs inhibited chemokine effects in vitro. This is attributed to physical proximity on the membrane between CD38 and CXCR4 (the CXCL12 receptor), as shown by (i) coimmunoprecipitation and (ii) confocal microscopy experiments. Blocking anti-CD38 mAbs significantly compromised homing of CLL cells from blood to lymphoid organs in a mouse model. These results indicate that CD38 synergizes with the CXCR4 pathway and support the working hypothesis that migration is a central step in disease progression.

Original languageEnglish
Pages (from-to)958-969
Number of pages12
JournalLeukemia
Volume24
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Monoclonal Antibodies
Disease Progression
CXCR4 Receptors
Lentivirus
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Chemotaxis
Chemokines
Confocal Microscopy
Ligation
Blood Cells
Clone Cells
Viruses
Membranes
Growth
Proteins

Keywords

  • CD38
  • Chemotaxis
  • Chronic lymphocytic leukemia
  • CXCL12/CXCR4
  • ERK1/2 phosphorylation

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Vaisitti, T., Aydin, S., Rossi, D., Cottino, F., Bergui, L., D'Arena, G., ... Deaglio, S. (2010). CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia, 24(5), 958-969. https://doi.org/10.1038/leu.2010.36

CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. / Vaisitti, T.; Aydin, S.; Rossi, D.; Cottino, F.; Bergui, L.; D'Arena, G.; Bonello, L.; Horenstein, A. L.; Brennan, P.; Pepper, C.; Gaidano, G.; Malavasi, F.; Deaglio, S.

In: Leukemia, Vol. 24, No. 5, 05.2010, p. 958-969.

Research output: Contribution to journalArticle

Vaisitti, T, Aydin, S, Rossi, D, Cottino, F, Bergui, L, D'Arena, G, Bonello, L, Horenstein, AL, Brennan, P, Pepper, C, Gaidano, G, Malavasi, F & Deaglio, S 2010, 'CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells', Leukemia, vol. 24, no. 5, pp. 958-969. https://doi.org/10.1038/leu.2010.36
Vaisitti, T. ; Aydin, S. ; Rossi, D. ; Cottino, F. ; Bergui, L. ; D'Arena, G. ; Bonello, L. ; Horenstein, A. L. ; Brennan, P. ; Pepper, C. ; Gaidano, G. ; Malavasi, F. ; Deaglio, S. / CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. In: Leukemia. 2010 ; Vol. 24, No. 5. pp. 958-969.
@article{318e255767bf4b5a9012bcd6e613bbb3,
title = "CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells",
abstract = "Homing of chronic lymphocytic leukemia (CLL) cells to sites favoring growth, a critical step in disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 CLL patients was divided into migrating and nonmigrating subsets according to chemotaxis toward CXCL12. Migrating patients phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) proteins more than nonmigrating patients (P <0.0002). CD38 expression was the parameter most strongly associated with heightened CXCL12 signaling (P <0.0001), confirmed by independent statistical approaches. Consistent with this observation, CD38 CLL cells in samples with bimodal CD38 expression responded less to CXCL12 than the intact clone (P <0.003). Furthermore, lentivirus-induced de novo expression of CD38 was paralleled by increased responses to CXCL12, as compared with cells infected with a control virus. CD38 ligation with agonistic monoclonal antibodies (mAbs) enhanced CXCL12 signaling, whereas blocking anti-CD38 mAbs inhibited chemokine effects in vitro. This is attributed to physical proximity on the membrane between CD38 and CXCR4 (the CXCL12 receptor), as shown by (i) coimmunoprecipitation and (ii) confocal microscopy experiments. Blocking anti-CD38 mAbs significantly compromised homing of CLL cells from blood to lymphoid organs in a mouse model. These results indicate that CD38 synergizes with the CXCR4 pathway and support the working hypothesis that migration is a central step in disease progression.",
keywords = "CD38, Chemotaxis, Chronic lymphocytic leukemia, CXCL12/CXCR4, ERK1/2 phosphorylation",
author = "T. Vaisitti and S. Aydin and D. Rossi and F. Cottino and L. Bergui and G. D'Arena and L. Bonello and Horenstein, {A. L.} and P. Brennan and C. Pepper and G. Gaidano and F. Malavasi and S. Deaglio",
year = "2010",
month = "5",
doi = "10.1038/leu.2010.36",
language = "English",
volume = "24",
pages = "958--969",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells

AU - Vaisitti, T.

AU - Aydin, S.

AU - Rossi, D.

AU - Cottino, F.

AU - Bergui, L.

AU - D'Arena, G.

AU - Bonello, L.

AU - Horenstein, A. L.

AU - Brennan, P.

AU - Pepper, C.

AU - Gaidano, G.

AU - Malavasi, F.

AU - Deaglio, S.

PY - 2010/5

Y1 - 2010/5

N2 - Homing of chronic lymphocytic leukemia (CLL) cells to sites favoring growth, a critical step in disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 CLL patients was divided into migrating and nonmigrating subsets according to chemotaxis toward CXCL12. Migrating patients phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) proteins more than nonmigrating patients (P <0.0002). CD38 expression was the parameter most strongly associated with heightened CXCL12 signaling (P <0.0001), confirmed by independent statistical approaches. Consistent with this observation, CD38 CLL cells in samples with bimodal CD38 expression responded less to CXCL12 than the intact clone (P <0.003). Furthermore, lentivirus-induced de novo expression of CD38 was paralleled by increased responses to CXCL12, as compared with cells infected with a control virus. CD38 ligation with agonistic monoclonal antibodies (mAbs) enhanced CXCL12 signaling, whereas blocking anti-CD38 mAbs inhibited chemokine effects in vitro. This is attributed to physical proximity on the membrane between CD38 and CXCR4 (the CXCL12 receptor), as shown by (i) coimmunoprecipitation and (ii) confocal microscopy experiments. Blocking anti-CD38 mAbs significantly compromised homing of CLL cells from blood to lymphoid organs in a mouse model. These results indicate that CD38 synergizes with the CXCR4 pathway and support the working hypothesis that migration is a central step in disease progression.

AB - Homing of chronic lymphocytic leukemia (CLL) cells to sites favoring growth, a critical step in disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 CLL patients was divided into migrating and nonmigrating subsets according to chemotaxis toward CXCL12. Migrating patients phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) proteins more than nonmigrating patients (P <0.0002). CD38 expression was the parameter most strongly associated with heightened CXCL12 signaling (P <0.0001), confirmed by independent statistical approaches. Consistent with this observation, CD38 CLL cells in samples with bimodal CD38 expression responded less to CXCL12 than the intact clone (P <0.003). Furthermore, lentivirus-induced de novo expression of CD38 was paralleled by increased responses to CXCL12, as compared with cells infected with a control virus. CD38 ligation with agonistic monoclonal antibodies (mAbs) enhanced CXCL12 signaling, whereas blocking anti-CD38 mAbs inhibited chemokine effects in vitro. This is attributed to physical proximity on the membrane between CD38 and CXCR4 (the CXCL12 receptor), as shown by (i) coimmunoprecipitation and (ii) confocal microscopy experiments. Blocking anti-CD38 mAbs significantly compromised homing of CLL cells from blood to lymphoid organs in a mouse model. These results indicate that CD38 synergizes with the CXCR4 pathway and support the working hypothesis that migration is a central step in disease progression.

KW - CD38

KW - Chemotaxis

KW - Chronic lymphocytic leukemia

KW - CXCL12/CXCR4

KW - ERK1/2 phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=77952419807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952419807&partnerID=8YFLogxK

U2 - 10.1038/leu.2010.36

DO - 10.1038/leu.2010.36

M3 - Article

C2 - 20220774

AN - SCOPUS:77952419807

VL - 24

SP - 958

EP - 969

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -